Zhivka Dancheva, Sophiya Chausheva, Tanya Stoeva, Marina Dyankova, Tsvetelina Yordanova, Borislav Chaushev, Rostislav Marinov, Viktor Nikolov, Pavel Abushev, Georgi Todorov, Eleonora Dimitrova, Aneliya Klisarova, Deyan Anakievski
OBJECTIVE: Recently, gallium-68-prostate-specific membrane antigen-11 (68 Ga-PSMA-11) positron emission tomography/computed tomography (PET/CT) has become a key imaging method in prostate carcinoma staging and biochemical progression, with varying sensitivities in different studies (from 40% to 80%). After four years of experience with 68 Ga-PSMA-11 PET/CT, we found that it is possible to detect lesions with increased PSMA expression in patients with undetectable prostate specific antigen (PSA) levels after radical prostatectomy...
April 18, 2024: Hellenic Journal of Nuclear Medicine